Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

Journal:
Nature Medicine
Published:
Affiliations:
18
Authors:
33
Institutions Authors Share
UCLA Jonsson Comprehensive Cancer Center, United States of America (USA)
9.000000
0.28
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)
4.000000
0.13
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)
4.000000
0.13
Ohio State University Wexner Medical Center (OSUWMC), United States of America (USA)
3.000000
0.09
SWOG Statistics and Data Management Center, United States of America (USA)
1.500000
0.05
Fred Hutchinson Cancer Center, United States of America (USA)
1.500000
0.05
Northwestern University (NU), United States of America (USA)
1.000000
0.03
USC Norris Comprehensive Cancer Center, United States of America (USA)
1.000000
0.03
OU Health Sciences Center (OUHSC), United States of America (USA)
1.000000
0.03
St. Joseph's/Candler (SJ/C), United States of America (USA)
1.000000
0.03
Southeastern Medical Oncology Center (SMOC), United States of America (USA)
1.000000
0.03
KU Cancer Center, United States of America (USA)
1.000000
0.03
Virginia Mason Franciscan Health, United States of America (USA)
1.000000
0.03
Masonic Cancer Center, United States of America (USA)
1.000000
0.03
NIH National Cancer Institute (NCI), United States of America (USA)
1.000000
0.03